血药物度是否仍然是必要的? 重新考虑剂量-反应关系中的药理动力学联系
Nicolas Simon1, Katharina von Fabeck1
1Department of Clinical Pharmacology, APHM, Institut de Neurosciences de la Timone, UMR7289, CNRS, Hôpital Sainte Marguerite, CAP-TV, Aix Marseille University, Marseille, France.
Frontiers in pharmacology
|August 13, 2025
概括
血药物度并不总是预测药物效应所必需的. 一种因果推断方法建议更有针对性的使用血监测,适当时采用替代方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 因果推理因果推理
- 药物开发 药物开发
背景情况:
- 血药物度历史上将剂量与临床反应联系起来,为治疗药物监测和PK/PD建模提供了基础.
- 然而,许多病例表明血水平并不总是与药物的作用相关,特别是局部作用药物或具有活性代谢物的药物.
研究的目的:
- 批判性地评估血药物度的必要性和充分性,以预测药理效应.
- 探索评估药物作用超出系统水平的替代方法.
主要方法:
- 使用Judea Pearl的因果推理框架进行概念分析.
- 临床实例的审查,证明了血度和药物效应之间的分离.
- 关于血监测结构化决策框架的建议.
主要成果:
- 血度可能并不总是存在于从剂量到效果的因果途径上,有时会掩盖药理机制.
- 像受体占用成像和功能生物标志物这样的现代工具为药物作用提供了更丰富的见解.
结论:
- 倡导对血药物度监测的选择性,有针对性和情境敏感的应用.
- 建议在血水平没有信息性时采取替代方法,并警告不要过度使用.
相关概念视频
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
Nonlinear Pharmacokinetics: Overview
551
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
551
Drug Distribution: Plasma Protein Binding
6.7K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
6.7K
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
275
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
275
Nonlinear Pharmacokinetics: Role of Transporters
92
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
92
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
298
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
298


